These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2369555)

  • 21. Permanent alopecia after systemic chemotherapy: a clinicopathological study of 10 cases.
    Miteva M; Misciali C; Fanti PA; Vincenzi C; Romanelli P; Tosti A
    Am J Dermatopathol; 2011 Jun; 33(4):345-50. PubMed ID: 21430504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A three-year follow-up study of psoriasis patients treated with low dosages of etretinate orally and corticosteroids topically.
    Polano MK; van der Rhee HJ; van der Schroeff JG
    Acta Derm Venereol; 1982; 62(4):361-4. PubMed ID: 6183880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical, ultrastructural and biochemical effects of an aromatic retinoid (etretinate) on psoriasis and Darier's disease.
    Lauharanta J
    Acta Derm Venereol Suppl (Stockh); 1982; 101():1-29. PubMed ID: 6954822
    [No Abstract]   [Full Text] [Related]  

  • 24. Topical odorant application of the specific olfactory receptor OR2AT4 agonist, Sandalore
    Jimenez F; López E; Bertolini M; Alam M; Chéret J; Westgate G; Rinaldi F; Marzani B; Paus R
    J Cosmet Dermatol; 2021 Mar; 20(3):784-791. PubMed ID: 32645251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the effects of a hair lotion in women with acute telogen effluvium: a randomized controlled study.
    Turlier V; Darde MS; Loustau J; Mengeaud V
    J Eur Acad Dermatol Venereol; 2021 Nov; 35 Suppl 2():12-20. PubMed ID: 34668237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alopecia: histologic changes.
    Bergfeld WF
    Adv Dermatol; 1989; 4():301-20; discussion 321. PubMed ID: 2701796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of an aromatic retinoid, Tigason (etretinate), in the treatment of Darier's disease.
    Burge SM; Wilkinson JD; Miller AJ; Ryan TJ
    Br J Dermatol; 1981 Jun; 104(6):675-9. PubMed ID: 7248178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hair and systemic disease.
    Sperling LC
    Dermatol Clin; 2001 Oct; 19(4):711-26, ix. PubMed ID: 11705356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hair disorders associated with autoimmune connective tissue diseases.
    Cassano N; Amerio P; D'Ovidio R; Vena GA
    G Ital Dermatol Venereol; 2014 Oct; 149(5):555-65. PubMed ID: 24975949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients with profuse hair shedding may reveal anagen hair dystrophy: a diagnostic clue of alopecia areata incognita.
    Quercetani R; Rebora AE; Fedi MC; Carelli G; Mei S; Chelli A; Poli E
    J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):808-10. PubMed ID: 20946585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eczema herpeticum in a patient with Darier's disease during treatment with etretinate.
    Verner E; Shteinfeld M; Zuckerman F
    J Am Acad Dermatol; 1985 Oct; 13(4):678-80. PubMed ID: 4078062
    [No Abstract]   [Full Text] [Related]  

  • 32. Chronic telogen effluvium is due to a reduction in the variance of anagen duration.
    Gilmore S; Sinclair R
    Australas J Dermatol; 2010 Aug; 51(3):163-7. PubMed ID: 20695853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hair darkening and new growth associated with etretinate therapy.
    Vesper JL; Fenske NA
    J Am Acad Dermatol; 1996 May; 34(5 Pt 1):860. PubMed ID: 8632091
    [No Abstract]   [Full Text] [Related]  

  • 34. Anagen effluvium.
    Kanwar AJ; Narang T
    Indian J Dermatol Venereol Leprol; 2013; 79(5):604-12. PubMed ID: 23974578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A proprietary herbal extract against hair loss in androgenetic alopecia and telogen effluvium: a placebo-controlled, single-blind, clinical-instrumental study.
    Pekmezci E; Dündar C; Türkoğlu M
    Acta Dermatovenerol Alp Pannonica Adriat; 2018 Jun; 27(2):51-57. PubMed ID: 29945259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted Nutritional Supplementation for Telogen Effluvium: Multicenter Study on Efficacy of a Hydrolyzed Collagen, Vitamin-, and Mineral-Based Induction and Maintenance Treatment.
    Arias EM; Floriach N; Moreno-Arias G; Camps A; Arias S; Trüeb RM
    Int J Trichology; 2022; 14(2):49-54. PubMed ID: 35531488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Etretinate therapy causes increases in lipid levels in patients with psoriasis.
    Ellis CN; Swanson NA; Grekin RC; Goldstein NG; Bassett DR; Anderson TF; Voorhees JJ
    Arch Dermatol; 1982 Aug; 118(8):559-62. PubMed ID: 7103524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telogen elongation in the hair cycle of ob/ob mice.
    Tasaki N; Minematsu T; Mugita Y; Ikeda S; Nakagami G; Sanada H
    Biosci Biotechnol Biochem; 2016; 80(1):74-9. PubMed ID: 26239026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telogen effluvium after allergic contact dermatitis of the scalp.
    Tosti A; Piraccini BM; van Neste DJ
    Arch Dermatol; 2001 Feb; 137(2):187-90. PubMed ID: 11176691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Miliacin encapsulated by polar lipids stimulates cell proliferation in hair bulb and improves telogen effluvium in women".
    Keophiphath M; Courbière C; Manzato L; Lamour I; Gaillard E
    J Cosmet Dermatol; 2020 Feb; 19(2):485-493. PubMed ID: 31135099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.